Trovagene Investor Relations http://trovagene.investorroom.com/ Trovagene Investor Relations Trovagene to Present at the Pioneers 2017 Joseph Gunnar Conference on May 2, 2017 in New York City http://trovagene.investorroom.com/2017-04-25-Trovagene-to-Present-at-the-Pioneers-2017-Joseph-Gunnar-Conference-on-May-2-2017-in-New-York-City Tue, 25 Apr 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-04-25-Trovagene-to-Present-at-the-Pioneers-2017-Joseph-Gunnar-Conference-on-May-2-2017-in-New-York-City Maxim Group Upgrades Trovagene from "Hold" to "Buy" http://trovagene.investorroom.com/press-releases?item=203 Revised model factoring in PCM-075 (AML drug) as the key driver of the company going forward - sets $4 target price. Thu, 13 Apr 2017 15:06:00 -0700 http://trovagene.investorroom.com/press-releases?item=203 Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board http://trovagene.investorroom.com/2017-04-13-Trovagene-Announces-the-Addition-of-Dr-Sandra-Silberman-to-its-Clinical-Advisory-Board Thu, 13 Apr 2017 09:41:00 -0700 http://trovagene.investorroom.com/2017-04-13-Trovagene-Announces-the-Addition-of-Dr-Sandra-Silberman-to-its-Clinical-Advisory-Board Taking the Next Step - Adding in A Precision Cancer Therapeutic to the Platform - Upgrading to Buy http://trovagene.investorroom.com/Taking-The-Next-Step-Adding-in-A-Precision-Cancer-Therapeutic-to-the-Platform-Upgrading-to-Buy Maxim Group upgrades Trovagene from a "hold" position to a "buy" position based on PCM-075 (AML drug candidate) as the key driver of the company going forward Wed, 12 Apr 2017 12:43:00 -0700 http://trovagene.investorroom.com/Taking-The-Next-Step-Adding-in-A-Precision-Cancer-Therapeutic-to-the-Platform-Upgrading-to-Buy Trovagene to Present at The MicroCap Conference on April 4, 2017 in New York City http://trovagene.investorroom.com/2017-03-27-Trovagene-to-Present-at-The-MicroCap-Conference-on-April-4-2017-in-New-York-City Mon, 27 Mar 2017 05:00:00 -0700 http://trovagene.investorroom.com/2017-03-27-Trovagene-to-Present-at-The-MicroCap-Conference-on-April-4-2017-in-New-York-City